Tokyo, Japan

Koki Ueno

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Toray Industries, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koki Ueno. Retrieved from https://idiyas.com/inventor/koki-ueno-peopjrgc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Koki Ueno - Innovator in Antipruritic Agents

Introduction

Koki Ueno is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for specific medical conditions. His innovative work focuses on addressing pruritus caused by multiple sclerosis.

Latest Patents

Koki Ueno holds a patent for an antipruritic agent specifically designed to alleviate pruritus associated with multiple sclerosis. This patent, which is a significant advancement in medical treatment, involves an effective ingredient that is a κ-opioid receptor agonist compound. The compound features a 4,5-epoxymorphinan skeleton and includes a specific chemical structure, such as Compound 1.

Career Highlights

Ueno is affiliated with Toray Industries, Inc., a leading company in the field of advanced materials and pharmaceuticals. His work at Toray has allowed him to focus on innovative solutions that address complex health issues. Ueno's dedication to research and development has positioned him as a key figure in his field.

Collaborations

Throughout his career, Koki Ueno has collaborated with esteemed colleagues, including Hideo Umeuchi and Hiroshi Miyakawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Koki Ueno's contributions to the development of antipruritic agents highlight his commitment to improving patient care. His innovative approach and collaboration with other experts in the field continue to drive advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…